Separation detection method of apremilast and apremilast enantiomer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUZHOU YABAO PHARMA R&D CO LTD
- Publication Date
- 2015-07-22
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical analytical chemistry, in particular to a separation and detection method for apremilast and its enantiomers. Background technique
[0002] Apremilast is a phosphodiesterase inhibitor. It is the first small-molecule drug approved by the FDA on March 21, 2014 for the treatment of arthritis caused by psoriasis. The original research company is Celgene. The chemical structural formula is as follows:
[0003]
[0004] Separation of enantiomers containing chiral carbon atoms has always been a difficult point in quality control during the synthesis and preparation of chiral drugs. Apremilast is a chiral drug. In order to ensure the safety of the drug, it is necessary to detect the content of enantiomer impurities in the drug in the quality standard. Enantiomers cannot be separated by conventional high-performance liquid chromatography and must be separated using a suitable chiral column.
[0005] Chin...